European Healthtech startup funding raised during Q2 2019.
In Q2 2019, 105 European Healthtech companies raised a combined €826M across 105 funding rounds, up 63433.5% versus Q2 2018. France led by capital raised, and Capital Cell was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| docplanner | Series D+ | Apr 2019 | €80M |
| Bioserenity | Series B | Apr 2019 | €65M |
| Promethera Biosciences | Series D+ | Apr 2019 | €40M |
| Imcyse | Series B |
| Acquisition |
| Apr 2019 |
| €40M |
| Apr 2019 |
| €35M |
| DNA Script | Series B | Apr 2019 | €34M |
| Confo Therapeutics | Series A | Apr 2019 | €30M |
| Micreos | Other | Apr 2019 | €30M |
| Zava | Series A | Apr 2019 | €28M |
| DayTwo | Series B | Apr 2019 | €28M |
| LetsGetChecked | Series B | Apr 2019 | €27M |
| AIDoc | Series B | Apr 2019 | €24M |
| Agomab Therapeutics | Series A | Apr 2019 | €21M |
| Lifen | Series B | Apr 2019 | €20M |
| Qare | Series B | Apr 2019 | €20M |
| Rapid Medical | Other | Apr 2019 | €18M |
